News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ViveBio Introduces Next-Generation ViveST™ Matrix to Expand Healthcare Access and Lower Specimen Transportation Costs


6/26/2013 9:39:56 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALPHARETTA, Ga., June 26, 2013 /PRNewswire/ -- ViveBio, LLC announced today the introduction of its next-generation ViveST proprietary matrix for the storage and transportation of biological specimens, expanding sample collection to remote areas and lowering specimen transportation costs. With the new matrix, the dried sample can be easily reconstituted into a robust specimen that can be used in multiple downstream applications including RNA/DNA targets, cell recovery, and protein analysis allowing for use with such tests as viral load quantification, genotyping and sequencing.

ViveST is a high volume, dried specimen storage and transportation system that allows the specimen to be handled without refrigeration. The device is intended to be used for biological specimens as an alternative to frozen plasma or dried blood spots. The benefits of ViveST include:

  • Ambient transport and storage of specimens eliminating the time and cost of preparing and shipping frozen samples
  • Easy to use workflow with rapid turnaround time
  • High sample volume of 1.0-1.5 mL that is often required for testing

The key feature of the ViveST is a proprietary absorbent matrix on which a biological specimen can be loaded by simple pipetting and allowed to dry. During the drying process, water in the biological sample is evaporated but biological analytes including proteins, virions and nucleic acids remain in the matrix.

ViveST is CE marked and has received ANVISA medical device registration in Brazil. Performance data using this next-generation matrix was recently presented at the International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies held June 4-8, 2013 in Toronto, Canada and the 29th Clinical Virology Symposium held April 28-May 1, 2013 in Daytona Beach, Florida. For more information regarding ViveST and recent scientific publications and posters, please visit the ViveBio website at www.vivebio.com or contact Richard Carroll, PhD, at carroll@vivebio.com or Brad Nelson at nelson@vivebio.com or 877-814-7004.

About ViveBio, LLC

ViveBio, LLC is a privately held biotechnology company focused on providing cost-effective solutions for biological specimen transportation and storage. ViveBio's mission is to expand access to healthcare and extend life through these cost effective solutions and other breakthrough technologies. The company's initial focus has been to address the need for transporting plasma for HIV, Hepatitis C and Hepatitis B viral load and genotype tests. ViveBio's manufacturing and corporate office is located in Alpharetta, Georgia.

SOURCE ViveBio, LLC



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES